Metformin Cost in South Dakota 2026

What Does Metformin Actually Cost at South Dakota Pharmacies?

Generic metformin tablets run roughly $8 per month at most South Dakota retail pharmacies in 2026 when paying cash, compared with a manufacturer list price of about $40 per month. The gap exists because metformin has been off-patent for decades and multiple manufacturers compete fiercely on price. At Walmart and Sam's Club pharmacies participating in the $4 generic drug program, a 30-day supply of metformin 500 mg or 850 mg often falls at or below that benchmark without any coupon.

Metformin hydrochloride was first approved by the FDA for type 2 diabetes management in adults in 1994 [1]. Because it is on the FDA's list of essential medicines and is produced by dozens of generic manufacturers, retail competition keeps cash prices low across the country, and South Dakota is no exception.

Prices do vary by pharmacy. A 90-day supply (three months) typically runs $12, $24 at chains such as Walgreens, CVS, and Hy-Vee when a free GoodRx coupon is applied, compared with $20, $35 without one. Independent rural pharmacies in South Dakota, which serve a large share of the state's dispersed population, sometimes price slightly higher, though discount cards close most of that gap.

The extended-release formulation, metformin ER (also sold as Glucophage XR generically), costs somewhat more, often $15, $30 per month cash-pay, because fewer manufacturers produce it and tablet coating adds manufacturing cost. Patients tolerating standard-release metformin well have no clinical reason to switch solely for cost savings [2].

The Diabetes Prevention Program Outcomes Study (DPPOS), which followed participants for more than 15 years, showed that metformin reduced progression from prediabetes to type 2 diabetes by 31% compared with placebo over 10 years [3]. Given that reduction, cost barriers matter: even an $8-per-month expense is not trivial for South Dakota households near the federal poverty line.

Does South Dakota Medicaid Cover Metformin?

South Dakota Medicaid does not currently cover metformin as a standard formulary benefit for type 2 diabetes or prediabetes in 2026. This is an important coverage gap, because roughly 11.6% of South Dakota adults have diagnosed diabetes according to CDC surveillance data [4], and a meaningful portion of them rely on Medicaid for health coverage.

Medicaid formulary decisions in South Dakota are administered by the South Dakota Department of Social Services. Enrollees who need metformin should ask their prescriber to submit a prior authorization request, which may be approved in documented cases of medical necessity, though approval rates for metformin specifically are not publicly reported by the state.

The American Diabetes Association's 2024 Standards of Care name metformin as a first-line pharmacologic agent for type 2 diabetes management [5]. That guideline designation strengthens prior-authorization arguments, but it does not guarantee approval under state Medicaid rules.

Dual-eligible patients (those covered by both Medicare and Medicaid) may find metformin covered under a Medicare Part D plan, since most Part D formularies place generic metformin in Tier 1 with a $0, $5 copay. Checking the Medicare Plan Finder at cms.gov is the fastest way to confirm a specific plan's cost-sharing.

South Dakota's Children's Health Insurance Program (CHIP), administered under the same department, covers pediatric patients with type 2 diabetes and may cover metformin for children age 10 and older, consistent with FDA labeling [1]. Families should verify with their CHIP caseworker.

Is Compounded Metformin Legal in South Dakota?

Compounded metformin is legal in South Dakota when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. The FDA's framework for 503A pharmacies, established under the Drug Quality and Security Act of 2013, permits pharmacies to compound drugs, including metformin, for individual patients when a licensed prescriber issues the prescription [6].

South Dakota follows federal 503A guidelines without additional state-level restrictions that would prohibit metformin compounding specifically. Compounding pharmacies in the state must hold an active South Dakota Board of Pharmacy license, and out-of-state 503A pharmacies shipping compounded metformin into South Dakota must comply with South Dakota's non-resident pharmacy permit requirements.

Why would a patient want compounded metformin when commercial generic tablets cost only $8 per month? Some telehealth platforms that specialize in metabolic health or longevity medicine dispense compounded metformin at no direct patient cost as part of a broader subscription, effectively bringing the monthly drug cost to $0. Compounding also allows alternative delivery forms, such as metformin in combination with berberine or in liquid suspension for patients who cannot swallow tablets.

Clinically, compounded metformin carries the same mechanism of action as the FDA-approved generic: it reduces hepatic glucose production, improves peripheral insulin sensitivity, and modestly lowers intestinal glucose absorption [7]. The UKPDS 34 trial (N=753 overweight patients with type 2 diabetes) demonstrated that metformin reduced all-cause mortality by 36% and myocardial infarction by 39% compared with conventional diet therapy over a median 10.7 years [8]. Compounded versions are not independently tested for bioequivalence to the FDA-approved reference product, so patients switching from commercial generic to compounded metformin should monitor fasting glucose for the first four to six weeks.

Can Telehealth Providers Prescribe Metformin in South Dakota?

Telehealth prescribing of metformin is permitted in South Dakota. State law allows a prescriber licensed in South Dakota to establish a valid prescriber-patient relationship via synchronous audio-video telemedicine and issue a prescription for a non-controlled medication like metformin without an in-person visit [9].

Metformin is not a controlled substance under the DEA Controlled Substances Act, so the Ryan Haight Act restrictions that complicate telehealth prescribing of buprenorphine or stimulants do not apply here. A board-certified physician, nurse practitioner, or physician assistant practicing via a telehealth platform can legally order metformin for a South Dakota patient after a video or telephone visit that meets state clinical-encounter standards.

Practical telehealth workflows for South Dakota patients typically involve:

1. Completing an online intake form with medical history, current medications, and HbA1c or fasting glucose results.
2. A 15, 20-minute video consult with a licensed provider.
3. A prescription sent electronically to the patient's chosen South Dakota pharmacy or to the platform's affiliated 503A compounding pharmacy.

Because South Dakota is geographically large with significant rural population, telehealth access to metformin may genuinely reduce barriers for patients in communities without nearby endocrinology or primary-care services. The CDC estimates that 38% of American adults have prediabetes, many of whom are undiagnosed [4], and telehealth-initiated metformin has been shown to reach patients who would not otherwise engage with in-person care.

A 2022 study in JAMA Internal Medicine found that telemedicine encounters for diabetes management produced glycemic outcomes not statistically different from in-person care at 12 months (HbA1c reduction 1.1% vs. 1.0%, P<0.05) [10]. South Dakota patients can reasonably expect similar outcomes when telemedicine visits are coupled with structured follow-up lab monitoring.

Which Insurance Plans Cover Metformin in South Dakota?

Most commercial insurance plans available through South Dakota's ACA marketplace and employer-sponsored group plans cover generic metformin on Tier 1 of their formulary, meaning the copay is typically $0, $10 per 30-day fill. Metformin's status as a generic essential medicine makes it one of the most reliably covered drugs across plan types [11].

Specific plans available in South Dakota through the ACA marketplace include offerings from Wellmark Blue Cross Blue Shield and Sanford Health Plan. Both carriers' standard formularies list generic metformin at Tier 1 as of 2026. Copay amounts are plan-specific, so reviewing the Summary of Benefits and Coverage (SBC) document or calling the plan's pharmacy benefit line is the fastest way to confirm exact cost-sharing.

Medicare Part D, as noted above, almost universally covers generic metformin at Tier 1. The Inflation Reduction Act's $35 monthly insulin cap does not directly affect metformin pricing, but the Act's broader drug-pricing provisions have maintained downward pressure on generic prices overall [12].

Patients who are uninsured or whose insurance does not cover metformin should use a GoodRx or RxSaver coupon at the point of sale. These free discount cards regularly bring the cash price at South Dakota pharmacies to the $4, $8 range regardless of insurance status.

What Is the Cheapest Way to Get Metformin in South Dakota?

The cheapest accessible options for most South Dakota residents in 2026, ranked by expected monthly out-of-pocket cost, are:

$0/month. A telehealth platform that bundles compounded metformin with the subscription fee, dispensed via a licensed 503A pharmacy. Cost depends on the platform's subscription rate; the metformin itself is listed as included. Patients should verify the platform's prescriber licensure in South Dakota and the compounding pharmacy's Board of Pharmacy standing.

$4/month. Walmart's $4 generic drug list covers metformin 500 mg and 850 mg (30-day supply) at South Dakota Walmart pharmacy locations. No insurance or savings card required.

$8/month. Average cash price at most South Dakota retail pharmacies, often achievable with a free GoodRx coupon. Publix and Kroger-affiliated pharmacies operate similar free-antibiotic/generic programs, though Kroger's South Dakota footprint is limited.

$10, $15/month. Tier 1 copay under most ACA marketplace and employer-sponsored plans in South Dakota.

Up to $40/month. Manufacturer list price without insurance or discount card. No patient should pay this amount for generic metformin.

The Diabetes Prevention Program (DPP) trial (N=3,234) showed that metformin 850 mg twice daily reduced diabetes incidence by 31% vs. placebo, with cost-effectiveness ratios that remained favorable even at full retail pricing over 10-year time horizons [3]. Keeping the actual acquisition cost at $4, $8/month makes metformin one of the most cost-effective medications available anywhere in U.S. medicine.

Metformin Dosing, Safety, and Monitoring Relevant to Cost Planning

Understanding dosing helps patients plan monthly supply needs accurately and avoid over-paying for quantity they do not need.

Standard starting dose is 500 mg twice daily with meals, titrated to a maintenance dose of 1 to 000 mg twice daily over four to eight weeks to minimize gastrointestinal side effects [1]. The FDA-approved maximum dose is 2 to 550 mg per day, though most patients achieve adequate glycemic control at 2 to 000 mg per day [13].

For a patient on 1 to 000 mg twice daily (the most common maintenance dose), a 30-day supply requires 60 tablets of 1 to 000 mg or 120 tablets of 500 mg. Purchasing a 90-day supply at once reduces per-unit cost further at most pharmacies and reduces the number of pharmacy trips, which matters in rural South Dakota where the nearest pharmacy may be 30+ miles away.

Renal function monitoring is clinically required before initiation and at least annually thereafter. Metformin is contraindicated when estimated glomerular filtration rate (eGFR) falls below 30 mL/min/1.73 m² and requires dose adjustment when eGFR is 30 to 45 mL/min/1.73 m² [1]. An annual basic metabolic panel to check creatinine/eGFR typically costs $15, $40 cash-pay at South Dakota lab draw sites, and it is covered by most insurance plans as preventive lab work.

Vitamin B12 deficiency occurs in approximately 5.8 to 7.2% of long-term metformin users due to reduced ileal absorption, as documented in a 2010 analysis published in BMJ [14]. Annual B12 monitoring adds a modest lab cost but prevents a correctable deficiency. Oral B12 supplementation (1 to 000 mcg/day) costs roughly $4, $6/month, a cost patients on metformin should factor into their overall medication budget.

South Dakota-Specific Resources and Assistance Programs

Several assistance channels are available specifically to South Dakota residents.

The South Dakota Department of Health's Diabetes Prevention and Control Program coordinates with CDC-recognized DPP lifestyle programs across the state and can connect patients with prescribers who use metformin as part of structured prediabetes management [4]. Contact is available through the department's chronic disease division in Pierre.

Pharmaceutical manufacturer patient assistance programs (PAPs) for branded metformin products (Glucophage, Fortamet, Riomet) have income thresholds that most South Dakota patients taking the generic would not need, but patients on brand-name extended-release formulations prescribed for specific tolerability reasons may qualify for free or reduced-cost supply directly from the manufacturer.

The South Dakota 211 helpline (dial 2-1-1) can connect residents to local health assistance programs, federally qualified health centers (FQHCs), and Indian Health Service (IHS) facilities. IHS facilities serving South Dakota's nine federally recognized tribes dispense metformin at no cost to eligible Native American patients, a significant access channel given that American Indian/Alaska Native populations in South Dakota carry a disproportionate burden of type 2 diabetes [4].

The HealthRX Cost Decision Framework for South Dakota metformin patients: If you have commercial insurance, confirm Tier 1 coverage and pay the copay ($0, $10). If you are uninsured, use Walmart's $4 program or a GoodRx coupon at any major chain. If you are on Medicaid without coverage, ask your prescriber for prior authorization documentation citing ADA 2024 Standards of Care [5] and UKPDS 34 [8]. If you qualify for IHS services, use that channel first. Telehealth plus 503A compounding is the best route for patients in rural areas who want $0 drug cost combined with convenient prescribing.

Metformin's Clinical Evidence Base: Why the Drug Costs So Little and Delivers So Much

Metformin's price collapse reflects its age and competition, not any weakness in its evidence profile. The drug has been studied for over 60 years, and the evidence base spans tens of thousands of patients across major randomized controlled trials.

UKPDS 34 (Lancet, 1998; N=753) remains the landmark trial for metformin in type 2 diabetes. Overweight patients randomized to metformin showed a 32% reduction in any diabetes-related endpoint compared with conventional therapy (P<0.0001), a 36% reduction in all-cause mortality (P<0.011), and a 39% reduction in myocardial infarction (P<0.010) [8]. The trial investigators concluded: "Metformin may be the first-line pharmacological therapy of choice in the overweight diabetic patient."

The DPP trial (N=3,234, NEJM 2002) showed that metformin 850 mg twice daily reduced diabetes incidence by 31% compared with placebo (P<0.001) over an average 2.8-year follow-up, with the greatest effect in participants aged 25, 44 and those with higher baseline BMI [3].

A 2022 Cochrane review of metformin versus placebo or no treatment in type 2 diabetes (27 trials; N=8,239) found metformin reduced HbA1c by a mean of 1.1 percentage points and produced modest but consistent weight reduction compared with sulfonylureas [15]. The ADA's 2024 Standards of Care state: "Metformin remains the preferred initial pharmacologic agent for the treatment of type 2 diabetes due to its efficacy, safety, and low cost" [5].

Those data points make metformin one of the best-supported drugs in all of endocrinology. South Dakota patients paying $8/month for a medication that cuts myocardial infarction risk by 39% are receiving extraordinary value per dollar spent.